BR9916101A - Purificação de compostos de ciclopeptìdeos equinocandinos - Google Patents

Purificação de compostos de ciclopeptìdeos equinocandinos

Info

Publication number
BR9916101A
BR9916101A BR9916101-0A BR9916101A BR9916101A BR 9916101 A BR9916101 A BR 9916101A BR 9916101 A BR9916101 A BR 9916101A BR 9916101 A BR9916101 A BR 9916101A
Authority
BR
Brazil
Prior art keywords
acetic acid
fermentation
products
echinocandinic
purification
Prior art date
Application number
BR9916101-0A
Other languages
English (en)
Inventor
John Robert Dobbins
Eugene Paul Kroeff
Jeffrey Thomas Vicenzi
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BR9916101A publication Critical patent/BR9916101A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

"<PURIFICAçãO DE COMPOSTOS DE CICLOPEPTìDEOS EQUINOCANDINOS>". é descrito um método para separação e purificação de uma ampla variedade de produtos de ciclopeptídeo de fermentação contendo pelo menos um grupo amino protonável ( incluindo os compostos do tipo Equinocandinos deacilados ) de seus caldos de fermentação ou mistos e sistemas de processo parcialmente purificado absorvendo-se a mistura sobre um meio cromatográfico de fase reversa, hidrofóbico, e eluindo com um gradiente de ácido acético linear contínuo variando de 0,1% de ácido acético a 10,0% de ácido acético em volume em água. é também descrito um processo para remover subprodutos de aldeído de tripeptídeo dos produtos de fermentação por meio de um agente de derivatização.
BR9916101-0A 1998-12-09 1999-12-08 Purificação de compostos de ciclopeptìdeos equinocandinos BR9916101A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11152498P 1998-12-09 1998-12-09
PCT/US1999/029008 WO2000034315A2 (en) 1998-12-09 1999-12-08 Purification of echinocandin cyclopeptide compounds

Publications (1)

Publication Number Publication Date
BR9916101A true BR9916101A (pt) 2002-06-04

Family

ID=22339024

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9916101-0A BR9916101A (pt) 1998-12-09 1999-12-08 Purificação de compostos de ciclopeptìdeos equinocandinos

Country Status (17)

Country Link
US (1) US6506726B1 (pt)
EP (1) EP1137663B1 (pt)
JP (1) JP2003511345A (pt)
KR (1) KR20010101151A (pt)
CN (1) CN1337968A (pt)
AT (1) ATE338059T1 (pt)
AU (1) AU766091B2 (pt)
BR (1) BR9916101A (pt)
CA (1) CA2353930A1 (pt)
DE (1) DE69933046T2 (pt)
DK (1) DK1137663T3 (pt)
ES (1) ES2272096T3 (pt)
IL (1) IL143563A0 (pt)
PT (1) PT1137663E (pt)
RU (1) RU2001118849A (pt)
WO (1) WO2000034315A2 (pt)
ZA (1) ZA200104621B (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743777B1 (en) * 1992-03-19 2004-06-01 Eli Lilly And Company Cyclic peptide antifungal agents and process for preparation thereof
CN1345333A (zh) * 1999-03-03 2002-04-17 伊莱利利公司 棘白菌素/糖类复合物
JP2002538097A (ja) 1999-03-03 2002-11-12 イーライ リリー アンド カンパニー 薬学的経口ｅｃｂ処方物および組成物の作製方法
AU767956B2 (en) 1999-03-03 2003-11-27 Eli Lilly And Company Formation and anion-exchange of crystalline echinocandin ammonium salts
EP1156782B1 (en) * 1999-03-03 2005-05-04 Eli Lilly And Company Echinocandin pharmaceutical formulations containing micelle-forming surfactants
US6991800B2 (en) * 2002-06-13 2006-01-31 Vicuron Pharmaceuticals Inc. Antifungal parenteral products
CN101005859B (zh) * 2004-06-29 2012-08-15 利莱恩斯生命科学有限公司 灭病毒生物液体的制备方法
DE102004060750A1 (de) 2004-12-15 2006-07-13 Sanofi-Aventis Deutschland Gmbh Verfahren zur Deacylierung von Lipopeptiden
TW200826957A (en) 2006-10-16 2008-07-01 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Purification processes for echinocandin-type compounds
US9394340B2 (en) 2009-03-24 2016-07-19 Cadila Healthcare Limited Purification process for lipopeptides
CN102219832B (zh) * 2010-04-15 2013-08-21 上海天伟生物制药有限公司 一种氮杂环六肽或其盐的纯化方法
CN102336817B (zh) * 2010-07-16 2016-06-15 浙江震元制药有限公司 棘球白素b母核的分离方法
CN102432674B (zh) * 2010-09-29 2014-01-22 上海天伟生物制药有限公司 一种环脂肽化合物或其盐的纯化方法
EP2623611B1 (en) * 2010-09-30 2016-07-13 Shanghai Techwell Biopharmaceutical Co., Ltd Method for purifying cyclic lipopeptide or salt thereof
CN102153616A (zh) * 2010-12-27 2011-08-17 浙江海正药业股份有限公司 一种环己肽类化合物及其盐的分离纯化方法
EP3192803B1 (en) 2011-03-03 2020-12-09 Cidara Therapeutics, Inc. Antifungal agents and uses thereof
SI2699327T1 (sl) * 2011-04-20 2015-11-30 Xelia Pharmaceuticals Aps Postopek čiščenja mikafungina
CN102952178B (zh) * 2011-08-24 2016-04-27 华北制药集团新药研究开发有限责任公司 一种高纯度棘白霉素类化合物的制备方法
SI3677252T1 (sl) 2012-03-19 2024-02-29 Cidara Therapeutics, Inc. Sheme odmerjanja za spojine iz razreda ehinokandinov
CN103483427A (zh) * 2012-06-09 2014-01-01 浙江海正药业股份有限公司 一种棘白菌素类化合物的纯化方法
CN103910783B (zh) * 2014-04-23 2016-07-06 华北制药集团新药研究开发有限责任公司 一种高纯度棘白霉素b母核的制备方法
EP3058958B1 (en) 2015-02-23 2018-09-19 Selectchemie AG Anidulafungin composition
WO2017120471A1 (en) 2016-01-08 2017-07-13 Cidara Therapeutics, Inc. Methods for preventing and treating pneumocystis infections
ES2955711T3 (es) 2016-03-16 2023-12-05 Cidara Therapeutics Inc Regímenes de dosificación para el tratamiento de infecciones fúngicas
CN106248857A (zh) * 2016-07-15 2016-12-21 广西医科大学 利用薄层层析快速检测植物环肽的方法
MA49576A (fr) 2017-07-12 2021-04-07 Cidara Therapeutics Inc Compositions et méthodes pour le traitement d'infections fongiques

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4320052A (en) 1979-12-13 1982-03-16 Eli Lilly And Company Derivatives of A-30912A nucleus
US4293482A (en) 1979-12-13 1981-10-06 Eli Lilly And Company A-30912A Nucleus
US4293489A (en) 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912A nucleus
US4304716A (en) 1979-12-13 1981-12-08 Eli Lilly And Company S 31794/F-1 Nucleus
EP0294990A3 (en) * 1987-06-10 1990-05-09 Eli Lilly And Company Chromatographic purification process
US4874843A (en) 1987-12-03 1989-10-17 Eli Lilly And Company Chromatographic purification process
DK173802B1 (da) 1988-09-12 2001-11-05 Merck & Co Inc Præparat til behandling af Pneumocystis carinii infeksioner og anvendelse af et cyclohexapeptid til fremstilling af et lægemiddel mod Pneumocystis carinii infektioner
US5166135A (en) 1988-09-12 1992-11-24 Merck & Company, Inc. Method for the control of pneumocystis carinii
US5310726A (en) 1990-03-19 1994-05-10 Merck & Co., Inc. Lipopeptide compounds
CA2043762C (en) 1990-06-07 2001-05-29 Adam J. Kreuzman Lipopeptide deacylase
FI912873A (fi) 1990-06-18 1991-12-19 Fujisawa Pharmaceutical Co Ny polypeptidfoerening och foerfarande foer dess framstaellning.
CZ288974B6 (cs) 1992-03-19 2001-10-17 Eli Lilly And Company Acylový derivát echinocandinu, způsob jeho přípravy, farmaceutický prostředek s jeho obsahem a jeho pouľití
US5965525A (en) 1992-03-19 1999-10-12 Eli Lilly And Company Cyclic peptide antifungal agents
US5541160A (en) 1994-04-04 1996-07-30 Merck & Co., Inc. Antifungal and anti-pneumocystis compounds, compositions containing such compounds, and methods of use
US5646111A (en) 1995-04-07 1997-07-08 Eli Lilly And Company Cyclic peptide antifungal Agents
US5652213A (en) 1995-05-26 1997-07-29 Eli Lilly And Company Cyclic peptide antifungal agents
US5786325A (en) 1995-05-26 1998-07-28 Eli Lilly And Company Cyclic peptide antifungal agents and methods of making and using
US5618787A (en) 1995-05-26 1997-04-08 Eli Lilly And Company Cyclic peptide antifungal agents
US5629290A (en) 1995-05-26 1997-05-13 Eli Lilly And Company Cyclic peptide antifungal agents
US5629289A (en) 1995-07-25 1997-05-13 Eli Lilly And Company Cyclic peptide antifungal agents
JP2001503015A (ja) 1996-02-01 2001-03-06 イーライ・リリー・アンド・カンパニー 環状ペプチド抗真菌剤
US5696084A (en) 1996-08-16 1997-12-09 Abbott Laboratories Amino-lipopetide antifungal agents
AU8687798A (en) 1997-08-04 1999-02-22 Eli Lilly And Company Cyclic peptide antifungal agents
CA2255140A1 (en) 1997-12-23 1999-06-23 Eli Lilly And Company Echinocandin binding domain of 1,3-.beta.-glucan synthase
US6323176B1 (en) 1998-02-25 2001-11-27 Eli Lilly And Company Cyclic peptide antifungal agents
DK1107981T3 (da) 1998-08-20 2005-05-30 Lilly Co Eli Syntese af ringmodificerede, cykliske peptidanaloger
DE69917467D1 (de) 1998-08-28 2004-06-24 Lilly Co Eli Reversible borkomplexe von 1,2-(cis)-diol zyklischen peptiden
WO2000024694A1 (en) 1998-10-28 2000-05-04 Eli Lilly And Company Photochemical process for making 1-deoxy-2-keto derivatives
EP1140991A1 (en) 1998-12-16 2001-10-10 Eli Lilly And Company Cyclic peptide antifungal agents
AU2189500A (en) 1998-12-16 2000-07-03 Eli Lilly And Company Cyclic peptide antifungal agents having a sugar substituent
CN1345333A (zh) 1999-03-03 2002-04-17 伊莱利利公司 棘白菌素/糖类复合物
EP1156782B1 (en) 1999-03-03 2005-05-04 Eli Lilly And Company Echinocandin pharmaceutical formulations containing micelle-forming surfactants
AU767956B2 (en) 1999-03-03 2003-11-27 Eli Lilly And Company Formation and anion-exchange of crystalline echinocandin ammonium salts
JP2002538097A (ja) 1999-03-03 2002-11-12 イーライ リリー アンド カンパニー 薬学的経口ｅｃｂ処方物および組成物の作製方法

Also Published As

Publication number Publication date
US6506726B1 (en) 2003-01-14
CA2353930A1 (en) 2000-06-15
AU766091B2 (en) 2003-10-09
WO2000034315A2 (en) 2000-06-15
RU2001118849A (ru) 2003-08-10
EP1137663B1 (en) 2006-08-30
ATE338059T1 (de) 2006-09-15
AU3113200A (en) 2000-06-26
DE69933046D1 (de) 2006-10-12
ES2272096T3 (es) 2007-04-16
ZA200104621B (en) 2002-06-06
WO2000034315A8 (en) 2000-10-26
WO2000034315A3 (en) 2000-12-28
EP1137663A2 (en) 2001-10-04
PT1137663E (pt) 2006-12-29
CN1337968A (zh) 2002-02-27
KR20010101151A (ko) 2001-11-14
JP2003511345A (ja) 2003-03-25
IL143563A0 (en) 2002-04-21
DK1137663T3 (da) 2007-01-08
DE69933046T2 (de) 2007-09-13

Similar Documents

Publication Publication Date Title
BR9916101A (pt) Purificação de compostos de ciclopeptìdeos equinocandinos
MX9707909A (es) Purificacion de anticuerpos.
ATE249244T1 (de) Aktivierte verbindungen und verfahren zur herstellung und reiningung
DE59409712D1 (de) Verfahren zur chromatographischen reinigung und trennung von nucleinsäuregemischen
FR2603581B1 (fr) Procede pour isoler et purifier des aminoacides par chromatographie
GR3032728T3 (en) Purification of alpha-1 proteinase inhibitor using novel chromatographic separation conditions
BRPI0410685A (pt) processos de purificação de 1,3-propanodiol e composições
IL131394A0 (en) Chromatographic purification of chlorinated sucrose
SE8402861D0 (sv) Rening av biologiskt material
CA2223236A1 (en) Method for purifying thrombopoietin
WO2004026891A3 (en) Protein purification
Bishop et al. High-performance liquid chromatography of amino acids, peptides and proteins: XXI. The application of preparative reversed-phase high-performance liquid chromatography for the purification of a synthetic underivatised peptide
KR960004367A (ko) α1-안티카이모트립신의 제조방법
WO1999009004A3 (en) Process for preparing and/or purifying amido acid phenyl ester sulfonates
ATE268338T1 (de) Antibiotische cryptdin-peptide und verfahren zur ihrer verwendung
CA2306447A1 (en) Purification of molecules
CA2213577A1 (en) A process for the preparation of factor ix from biological sources
AU4263493A (en) Method for purifying an aqueous solution of raw albumin
HUT72924A (en) Displacement chromatography process and purified hemoglobin product
YU50499A (sh) Postupak za prečišćavanje procesne materije
FR2705342B1 (fr) Acétonitrile très purifié et procédé de purification d&#39;acétonitrile brut.
Dillon et al. HETEROGENEITY OF INSULIN: I. ISOLATION OF A CHROMATOGRAPHICALLY PURIFIED, HIGH-POTENCY INSULIN AND SOME OF ITS PROPERTIES
BR9813522A (pt) Processos para separar e purificar apm e metil éster de n-[n-(3,3-dimetilbutil)-l-alfa-aspartil]-l-fenilalanina e para a produção do derivado de apm, apm ou derivado de apm, e, adoçante
KR970043066A (ko) 본취용 역상 고압 액체 크로마토그래피(Prep-HPLC)를 이용한 반코마이신의 정제방법
Chang et al. Rapid purification of arrowhead proteinase inhibitors by high performance hydrophobic interaction chromatography on a PEG bonded phase column

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1962 DE 12/08/2008.